Arkstone's study suggests that AI can produce faster therapeutic recommendations than traditional methods. According to ...

The organization is providing trainers with information and education for how to coach clients taking the weight-loss ...

The organization was inspired to promote awareness for the disease in the wake of the former President’s diagnosis.

In an effort to promote the use of genuine products, Novo Nordisk is offering a one-time first-month offer for Wegovy at $199 ...

The biopharmaceutical sector is underpinned by a unique ecosystem that combines public funding for basic research, university ...

Heparin is a critical drug that is highly dependent on the global supply chain and is derived from a highly complex process.

Since joining the Lupus Research Alliance (LRA) in 2015, Albert T. Roy has risen to the role of president and CEO. During ...

Mercalis and PharmaCord announced the completion of their merger. The new company is rebranding itself as Valeris, which will ...

In this Pharmaceutical Executive exclusive, Bob Jansen, David Shulkin, Gen. Paul Funk (Ret.), and Maj. Gen. Dennis LeMaster ...

Across the board, oncologists are navigating a fast-changing landscape while managing full patient loads, reimbursement ...

Clearance of ASC50 paves the way for a Phase I trial in patients with mild-to-moderate plaque psoriasis.

Deal includes VG-3927, a first-in-class TREM2 agonist aimed at advancing next-generation Alzheimer disease therapies.